This review describes in detail the beneficial effects of GLP-1 RA on the central pathological mechanisms of diabetes and related degenerative diseases
We feel the initial resistance of the skin, the subtle pop as we enter the vein, and we adjust our angle and depth based on what were sensing
Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, et al
Part 1 of Our Series on GLP-1 Nutrition and Dietary Counseling Its been a truism for almost as long as there have been such things as professional nutritionists: most of the job is about explaining to people how to lose weight
Almost 50% of people taking GLP-1 medication think it's okay to ask someone about their use of weight-loss medication, but only in certain situations, such as: Close personal relationships: 64% Concern for health: 62% Professional/healthcare settings: 60% If they have posted about their weight loss journey online: 40% 3 in 4 people taking GLP-1 medication are transparent about their weight-loss medication use
Includes FDA black-box MTC family history, a pancreatitis question that goes as far as asking about elevated blood lipase levels, a GI conditions multi-select, and a comorbidity screen framed around insurance-approval support